Intranasal delivery of metal/metal oxide nanoparticles for the management of CNS-related diseases: theranostic and toxicity issues
Intranasal delivery of metallic NPs is an emerging strategy for drug delivery and imaging, particularly for targeting CNS disorders. However, the development of novel NPs with minimal neurotoxicity is crucial to ensuring their safety and efficacy for clinical applications.
Authors
- Maryam Azarfarin (ORCID: https://orcid.org/0009-0002-2815-459X)
- Samin Hamidi (ORCID: https://orcid.org/0000-0003-4161-196X)
- Fereshteh Valipour (ORCID: https://orcid.org/0000-0002-4126-3945)
- Sara Salatin (ORCID: https://orcid.org/0000-0001-9107-5603)
- Mitra Alami-Milani
- Shirin Ahmadi
- Zahra Esmaeili Moghaddam
Institutions
- Tabriz University of Medical Sciences (IR)
- Urmia University (IR)
- University of Tabriz (IR)
- Institute of Polymers (BG)
- Urmia University of Medical Sciences (IR)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1080/03639045.2025.2603418
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00